Skip to Content

Emisphere Technologies, Inc. 

Merger

  • Date:
  • 11/9/2020
  • Company Name:
  • Emisphere Technologies, Inc.
  • Stock Symbol:
  • EMIS
  • Company Name - Buyer:
  • Novo Nordisk A/S
  • Stock Symbol - Buyer:
  • NVO
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 11/6/2020

Case Finder

Locate any case using the tools below.

NEW YORK, November 9, 2020 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Emisphere Technologies, Inc. (Other OTC: EMIS) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Novo Nordisk A/S (NYSE: NVO).
 

On November 6, 2020, Emisphere announced that it had signed an agreement to be acquired by Novo Nordisk for approximately $1.34 billion.  Pursuant to the merger agreement, Emisphere stockholders will receive approximately $7.82 in cash for each share of Emisphere common stock owned.  The exact consideration will depend on the amount of cash and debt at the close of the deal. 

Bragar Eagel & Squire is concerned that Emisphere’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.  Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Emisphere’s stockholders.

The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Emisphere Technologies. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: